ReviewJournal of diabetes2019

Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.

Lance A SloanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.